Japan & Korea Allocator Intelligence

Edition #004

7 September 2026 · Covering 2026-08-31 to 2026-09-07 · 11 articles

Intelligence · Japan & Korea Allocator Intelligence

Week of August 31 – September 7, 2026

Five things this week

  1. A 3% JGB changes the question a Japanese insurer asks, not the answer. Lifers buy foreign credit hedged, so they never earned the dollar rate; the comparison is your credit spread against the 1.4–2.4 points of term premium a JGB now pays over yen cash. Senior direct lending still clears it at the top of its range, not at the bottom. → Lead
  2. Japan's megabanks' fund-finance lines are already under named FSA review. Four groups, three products (subscription, NAV, lending to private-credit funds), 68% of it in the Americas, three named data gaps. Bring the sponsor-level reporting to the next renewal. → Securities & Banks
  3. Korea's two biggest allocators have no CIO. NPS is more than a month past schedule with four finalists; KIC's search collapsed in July. Diligence continues, sign-off waits; build Q4 into the model. → Korea
  4. From 2027 a second solvency number sorts Korea's insurers. Six sit below the 50% basic-capital floor and are managing to a 2036 glide path; Samsung Life and Samsung Fire sit far above it and are shopping for platforms abroad. Qualify on the basic ratio first. → Korea
  5. Korea's real opening is bank retreat, not yield. Bad loans at an eight-year high (₩18.9tn), SME lending up 2% against 15% for large corporates, and five loss-making domestic NPL buyers. → Korea

How to read this edition. Each item opens with its conclusion in bold, then the evidence, then the GPs it fits and what they would need. Source links sit in numbered notes at the end; terms this edition uses are defined in the short glossary, and the full standing glossary lives at NL2 Standing Glossary.

Key Upcoming Events

Date Event Location Why It Matters for GPs
17–18 September 2026 BOJ policy meeting Tokyo Ueda has signalled a strong chance of a hike this month; a hike lifts yen short rates and JGB yields together, so hedged floating-rate arithmetic barely moves — but Japanese committees will wait for the decision
Early October 2026 Samsung Life / Samsung Fire disclosure deadline on PFG and Canopius Seoul Both companies committed to update the market by early October; a close removes several trillion won from the pool available for fund commitments this window
Year-end 2026 Japan's cabinet finalises the FY2027 budget Tokyo Fixes the actual instrument — grant, guarantee or tax credit — behind METI's ¥4.53tn AI/semiconductor line
~Late November 2026 (expected) FSS Q3 2026 bank asset-quality release Seoul Tests whether the NPL acceleration from March to June (0.60% → 0.63%) continues into a third consecutive record
1 January 2027 Korea's 50% basic K-ICS floor takes effect Seoul Starts the nine-year phase-in clock for insurers currently below the floor
2027 (timing not yet fixed) KIC Act amendment passage and Strategic Investment Account launch Seoul Targeted for National Assembly passage this year, with operations from 2027 — the first live mandate from Korea's new Temasek-style vehicle

Watchlist for Next Week

  1. GPIF — its next quarterly disclosure, for any drift toward the 31% domestic-bond ceiling that would signal a policy-mix change is already under way informally.

Glossary — terms used in this edition

The full standing glossary (33 Japan, Korea and cross-market terms) now lives at NL2 Standing Glossary. Below are only the terms this edition leans on.

Term What It Is Why GPs Should Care
J-ICS (Japan Insurance Capital Standard) New economic value-based solvency framework effective March 2026, replacing the old Solvency Margin Ratio. Assets and liabilities valued at market rates. This is the single biggest driver of Japanese insurer allocation to private credit. Your pitch must show how your fund impacts their ESR (see below).
ESR (Economic Solvency Ratio) The J-ICS capital ratio: own funds over required capital, both at market value. Legal minimum 100%; insurers set their own policy floors (Dai-ichi: 170% against a current 220%). Every allocation is judged by its ESR impact. Currency risk carries a 30% factor for dollars, so a hedged holding is almost free of it; a fund without look-through can fall into the 49% "other equities" bucket.
Subscription finance / NAV finance Two forms of fund-level leverage Japanese megabanks extend to overseas GPs: subscription finance lends against LPs' unfunded commitments; NAV finance lends against a fund's asset value. Japan's FSA now names both, plus BDC/private-credit-fund lending, as a supervised category at four megabank groups (MUFG, SMBC, Mizuho, Sumitomo Mitsui Trust). If your fund draws either facility from one of them, expect sponsor-level reporting questions at the next renewal.
NPS (National Pension Service / 국민연금) Korea's national pension fund, roughly ₩1,800tn (~$1.3tn) AUM. The dominant institutional investor in Korea. NPS sets the direction for the entire Korean pension complex. Its fund-management chief (CIO) seat is the single sign-off point for new large alternatives commitments — as of this edition, that seat has sat empty more than a month past schedule.
KIC (Korea Investment Corporation) Korea's sovereign wealth fund. Conservative mandate; now also home to a newly-approved, firewalled "Strategic Investment Account" — a Temasek-style direct-equity vehicle in strategic sectors, targeted to launch in 2027 pending an amendment to the KIC Act. Under the existing mandate's Total Portfolio Approach there is no "alternatives allocation" to fill — your strategy must prove its contribution versus liquid beta. The new Strategic Investment Account is a separate, not-yet-operating door: worth pre-positioning relationships for, not pitching yet.
National Growth Fund (국민성장펀드) A KDB-anchored policy fund-of-funds that selects mother-fund managers across leagues (national-participation, industry-support, scale-up/regional, ultra-long-term technology) to deploy state-backed growth capital, using public money as "priming water" to draw in a larger pool of private capital. Confirms KDB as an active FoF LP steering capital to government priorities, with a disclosed eligibility bar (mother-fund experience, AUM ≥ ₩1tn) and an annual public RFP calendar. For most foreign GPs the realistic entry is as a sub-fund manager selected by the mother-fund winners, not as the mother-fund manager itself.
CMC (Chinese Military Company) list The US Department of War's list of Chinese companies it deems to have military ties. Korean and Japanese institutions holding or investing in CMC-listed companies face rising scrutiny over that exposure. NPS's supervising ministry has, for the first time, conceded a screening gap on this point after NPS took part in the IPO of a newly-CMC-listed company. Expect Korean (and eventually Japanese) allocators to start asking GPs for documented CMC/US Entity List screening of portfolio companies.
K-ICS (Korean Insurance Capital Standard) Korea's economic-value solvency regime, in force since January 2023. Headline ratio: available over required capital. Legal minimum 100%; supervisors' recommended level 130% (cut from 150% in June 2025). Korean insurers already run their books on K-ICS charges; the pitch should name the charge for your strategy.
Basic K-ICS ratio From 1 January 2027: basic capital (equity, reserves, retained earnings and, within limits, perpetual hybrids — not subordinated debt) over required capital. Floor 50%; 80% to redeem basic-capital securities early; glide path to 50% by end-March 2036 for insurers below it. The number to check before any Korean insurer outreach: the headline ratio can be filled with subordinated debt, the basic ratio cannot.
Covered interest parity A currency forward is priced off the gap between the two currencies' short rates, so hedging dollars into yen costs roughly the dollar–yen short-rate gap plus a basis. A hedged Japanese investor never earns the dollar rate; it earns the yen short rate plus your credit spread, less the basis. The comparison is spread against JGB term premium, not US rates against Japanese rates.
JPY hedging cost The rate gap (about 2.2 points on 4 September 2026 using three-month T-bills against TIBOR; 2.65 on overnight rates) plus the cross-currency basis (15–20bp at the start of 2026, 35 at the April 2025 peak): 2.4–2.8 points a year all-in. Lead with spread over SOFR, less basis and fees, added to the yen short rate and set against the 10- and 30-year JGB — dated, and re-issued every quarter.
PRT (pension risk transfer) An insurer takes over a defined-benefit scheme's liabilities and funds them with matching assets. MS&AD's £200m stake in Standard Life's UK PRT venture is a template for a Japanese insurer backing named-GP origination; the liabilities set the currency and duration.
Mother fund (모태펀드) Korea's government-run fund-of-funds, which awards GP mandates by open round; its Overseas VC Global Fund account has a Co-GP track pairing Korean and foreign managers. The documented foreign-entry precedent (Shinhan + Global Brain, IMM + Venture Souq, Ascent + CICC in 2024). Build the Korean partner before the next round opens.

Caveats / unverified

  • GPIF figures are from GPIF's own first-quarter FY2026 results (¥320,373.2bn total, domestic bonds 25.59% at end-June 2026); the $2.0tn conversion is ours. The SocGen and Goldman headroom estimates date from July and use March weights.
  • Insurer ratio dates differ. Samsung Life 177% and Samsung Fire 160% are at 30 June 2026 (Samsung Life's Q2 call via Bloter; Korea Ratings via eKorea); DB Insurance 87.9% and Hyundai M&F 59.7% are end-2025; Hanwha 58.8% is Q1 2026 (its Q2 figure was not disclosed by 24 August); the six below 50% are end-June 2026.
  • Farallon at Nikkon is 23.0% on its own large-shareholding filing and 24.65% of voting rights on Nikkon's count as of 26 March 2026 (different denominators); the text uses the filing figure.
  • Dai-ichi's ESR sensitivity (−19 points for a 50bp fall in yen rates) is from its first new-basis disclosure, on March 2023 figures; it shows direction and order of magnitude, not today's number.
  • The yen basis. No primary observation for September 2026 was retrieved; the 15–20bp figure is the Banque de France's early-2026 range and 35bp its April 2025 peak. The 9–12% gross direct-lending range and the 1.5–3.0-point illiquidity premium are industry pricing, not quoted rates; the 1.5–2.5-point fee-and-carry deduction is illustrative.
  • MUFG's "over $30 billion" of committed subscription and NAV lending capacity is an undated claim on its own website with no second source. Why the Nikkon bidder pool narrowed from three to two is not explained by any source. MS&AD's interest in reinsurance broking rests on one Nikkei interview with no figures.
  • The MS&AD PRT reading — that the venture's currency and duration are set by its sterling liabilities and MS&AD's currency exposure sits at the equity stake — is our reading of the structure, not stated by the source.
  • K-ICS mechanics. The ₩100bn worked example is arithmetic on the disclosed shock factors before diversification. Regulators describe the 80% marker both as the recommended level and as the level needed to redeem basic-capital securities early; the text carries both. The FX shock is described without a factor because the KIRI report gives the mechanics, not the numbers.
  • KIC's strategic account. The ₩500bn (2.4%) cash slice is MoneyToday's breakdown; nothing is operating until the KIC Act amendment passes.
  • Since the window closed (8 September): the yen moved through 153, the health minister said GPIF is "continuing to consider" a review, and swap markets priced a September hike at 97–98%. None contradicts the Lead; none is in the body, which covers 31 August–7 September.

Disclaimer: Japan & Korea Allocator Intelligence is published for general information and education only. It is not investment advice, and it is not an offer, solicitation or recommendation to buy, sell or hold any financial instrument, nor an invitation to engage in any investment activity. Nothing in it takes account of any reader's circumstances, objectives or needs. Figures and sources are believed accurate at the dates shown, but completeness and continuing accuracy are not guaranteed. Take your own professional advice before acting on anything here.